Company: PFSA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004396
Chunk: 268

Company: Profusa, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 268
---
 a financial point of view.

In the event that we submit
our initial business combination to our public stockholders for a vote, our sponsor, executive officers, and directors have agreed to
vote their founder shares and any public shares purchased in or after our initial public offering in favor of our initial business combination.

The following table summarizes
the relevant pre-existing fiduciary or contractual obligations of our officers and directors:

    Individual 
    Entity 
    Position at affiliated entity
  
    Jack Stover 
    Onconova Therapeutics, Inc. 
    Director

    Fred Knechtel 
    - 
    -

    Peter O’Rourke 
    TCI Partners 
    Managing Partner

    AXIM Biotechnologies 
    Director

    Ed Johnson 
    iONEBIOSUSA 
    CEO

    Johnson Global Ventures LLC 
    CEO

    Advantage Capital Partners 
    Advisor

    Lauren Chung 
    MINLEIGH, LLC 
    CEO

    Todos Medical Ltd. 
    Director

Limitation on Liability and Indemnification
of Officers and Directors

Our amended and restated certificate
of incorporation provides that our officers and directors will be indemnified by us to the fullest extent authorized by Delaware law,
as it now exists or may in the future be amended. In addition, our amended and restated certificate of incorporation provides that our
directors will not be personally liable for monetary damages to us for breaches of their fiduciary duty as directors, except to the extent
such exemption from liability or limitation thereof is not permitted by the DGCL.

56

We entered into agreements
with our officers and directors to provide contractual indemnification in addition to the indemnification provided for in our amended
and restated certificate of incorporation. Our bylaws also permit us to maintain insurance on behalf of any officer, director or employee
for any liability arising out of his or her actions, regardless of whether Delaware law would permit such indemnification. We have obtained
a policy of directors’ and officers’ liability insurance that insures our officers and directors against the cost of defense,
settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.

These provisions may discourage
stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions also may have the effect
of reducing the likelihood of derivative litigation against officers and directors, even though such an action, if successful, might otherwise
benefit us and our stockholders.